Health Canada Approves Variant-Adapted Vaccine By BioNTech (BNTX)
BioNTech recently experienced a 10% price increase in the last quarter, coinciding with the Health Canada's authorization of its variant-adapted COMIRNATY COVID-19 vaccine, a potential positive catalyst. During this period,…
Share